Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Adults With Type 1 Diabetes
NCT01320345Phase 3Active, not recruiting
- Sponsor
- University of Sydney
- Start
- Nov 2016
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in diabetic retinopathy (DR) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Occurrence of clinical significant retinopathy progression up to 36 months. Started Nov 2016; status: active, not recruiting.
02
Drugs
fenofibrate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT01320345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320345.